RESUMEN
BACKGROUND: The frequent encounters of seafarers with people from different countries compared to other occupations increase their risk of contracting different variants of coronavirus disease 2019 (COVID-19). This risk may cause additional anxiety for them. The main purpose of this research is to determine the mediating role of COVID-19 burnout and intention to quit in the impact of seafarers' anxiety about contracting COVID-19 on work stress. MATERIALS AND METHODS: The research is a quantitative correlational research design cross-sectional study. We determined the research data according to the random sampling technique. Participants consist of 390 maritime business employees operating in Istanbul and Izmir. We determined the participants based on voluntary participation. We collected the data with the help of the Coronavirus Anxiety Scale, COVID-19 Burnout Scale, Intention to Quit Scale, and Work Stress Perception Scale. RESULTS: The study found that seafarers' anxiety about contracting the novel coronavirus positively influences their perception of job stress and that COVID-19 burnout and intention to quit strongly mediate this interaction. We also determined that seafarers had a high level of COVID-19 anxiety, leading to a higher perception of COVID-19 burnout. CONCLUSIONS: These findings mean that although personal factors are important, negative psychological perceptions feed off each other and cause another psychological perception. The research results need to be strengthened by psychological factors such as job satisfaction, organizational trust and organizational support, and their psychological resilience should be increased so that seafarers do not show COVID-19 anxiety due to job stress and intention to quit.
Asunto(s)
Agotamiento Profesional , COVID-19 , Estrés Laboral , Ansiedad/epidemiología , Agotamiento Profesional/epidemiología , COVID-19/epidemiología , Estudios Transversales , Humanos , Intención , Satisfacción en el Trabajo , Estrés Laboral/epidemiología , Estrés Laboral/psicología , Encuestas y CuestionariosRESUMEN
Objective: Cardiac involvement is common in Noonan syndrome (NS). Concerns have been raised regarding the effect of recombinant growth hormone (rGH) use on ventricular wall thickness and a possible increased risk of cardiac side effects. This study aimed to investigate the effect of rGH on the development of hypertrophic cardiomyopathy and other cardiac findings in NS. Methods: Patients under the age of 18 years and diagnosed with NS according to the Van der Burgt criteria, were included. Patients were divided into two groups according to those receiving rGH or not at the time of obtaining cardiac measurements. Before and after the treatment, electrocardiographic and echocardiographic (ECHO) assessments were made, including interventricular septal thickness, left ventricular internal diameter, and left ventricular posterior thickness. Results were expressed as Z scores. Results: Twenty-four NS subjects (16 boys, eight girls) were included. At the beginning of the follow up, the overall height standard deviation score was -2.56±0.94. Sixteen were on rGH. The mean rGH treatment duration was 8.3±3.8 years, and the mean dose was 0.22±0.04 mg/kg/week. The final height was 169±8.2 cm, and 10 of 11 patients who reached the final height received rGH. There was no difference between the rGH and non-rGH groups in terms of ECHO parameters pre-and post-treatment. Conclusion: In this cohort, there was no change in ECHO parameters on rGH and during follow-up. These results suggest that rGH is safe in NS patients with cardiac pathology under close follow-up.
Asunto(s)
Hormona de Crecimiento Humana , Síndrome de Noonan , Adolescente , Femenino , Humanos , Masculino , Estatura , Estudios de Seguimiento , Hormona de Crecimiento Humana/uso terapéutico , Síndrome de Noonan/tratamiento farmacológico , Proteínas Recombinantes/uso terapéuticoRESUMEN
BACKGROUND/AIM: The Neuropsychiatric Inventory-Clinician (NPI-C) scale is one of the best-known scales for evaluating the behavioral and psychological symptoms of dementia. This study aimed to assess the reliability and validity of the Turkish version of the NPI-C scale in patients with Alzheimer disease (AD). MATERIALS AND METHODS: The NPI-C scale was administered to 125 patients with AD. For reliability, both Cronbach's α and interrater reliability were analyzed. The Behavioral Pathology in Alzheimer's Disease (BEHAVE-AD) scale was applied for validity and, in addition, the Mini Mental State Examination (MMSE), Instrumental Activities of Daily Living (IADL) scale, and Disability Assessment of Dementia (DAD) scale were completed. RESULTS: The Turkish version of the NPI-C scale showed high internal consistency (Cronbach's α = 0.75) and mostly good interrater reliability. Assessments of validity showed that the NPI-C and corresponding BEHAVE-AD domains were found to be significantly correlated, between 0.925 and 0.195. Moreover, the correlations between NPI-C and MMSE were significant for all domains except the dysphoria, anxiety, and elation/euphoria domains. When we conducted a correlation analysis of NPI-C with IADL, all domains were statistically significantly correlated except aggression, anxiety, elation/euphoria, and dysphoria. CONCLUSION: The Turkish version of the NPI-C scale was found to be a reliable and valid instrument to assess neuropsychiatric symptoms in Turkish elderly subjects with AD.